glyburide has been researched along with tak-875 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Li, Z; Qian, H; Wang, X; Xia, W; Xu, X; Yang, J; Zhou, X | 1 |
| Huang, W; Jiao, L; Li, Z; Pan, M; Qian, H; Qiu, Q; Su, X; Wang, X; Xu, X | 1 |
| Cai, X; Dai, Y; Fu, M; Huang, W; Li, Z; Pan, M; Qian, H; Shi, W; Su, X | 1 |
| Arnoult, E; Gunnet, J; Hall, M; Huang, H; Liu, J; Martin, T; Meegalla, SK; Otieno, M; Paul Lee, S; Player, MR; Pocai, A; Rady, B; Silva, J; Wang, Y; Xu, J; Zhao, S | 1 |
| Feng, D; Huang, W; Li, Z; Liu, C; Qian, H; Tong, J; Yang, J; Ye, Z; Yue, N; Zhou, J | 1 |
| Ito, R; Matsuda, K; Miyawaki, K; Suzuki, M; Takeuchi, K; Tsujihata, Y | 1 |
6 other study(ies) available for glyburide and tak-875
| Article | Year |
|---|---|
Design, synthesis and biological activity of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists.
Topics: Acetates; Animals; Binding Sites; Calcium; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Type 2; Drug Design; Glucose Tolerance Test; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Molecular Docking Simulation; Protein Structure, Tertiary; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2015 |
Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
Topics: Animals; Blood Glucose; CHO Cells; Cricetulus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Design; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thiazoles | 2016 |
Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
Topics: Administration, Oral; Animals; Biological Availability; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Discovery; Glucose Tolerance Test; Male; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Pyrroles; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2016 |
Discovery of a novel potent GPR40 full agonist.
Topics: Animals; Benzofurans; Biphenyl Compounds; CHO Cells; Cricetulus; Dogs; Glucagon-Like Peptide-1 Receptor; Glucuronides; Humans; Hypoglycemic Agents; Macaca fascicularis; Mice; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Phenylpropionates; Piperidines; Pyrazines; Pyrimidines; Rats; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Sulfones | 2018 |
Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold.
Topics: Acetates; Animals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Design; Glucose Tolerance Test; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2019 |
Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.
Topics: Animals; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Drug Synergism; Glucose Tolerance Test; Glyburide; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; Sulfones; Sulfonylurea Compounds | 2016 |